KMB Cuts 2026 Outlook as China Diaper Disruption Clouds Growth View

Why KMB Lowered Its 2026 Outlook

Kimberly-Clark now expects 2026 organic sales growth to run approximately 100 basis points below weighted-average category growth in the countries and categories where it competes. Those categories were growing about 2% on a trailing-12-month basis.

The revised view primarily reflects realized and potential companywide effects from the China social-media disruption, which management estimates at roughly 100 basis points for 2026. Adjusted operating profit is still expected to grow at a mid-single-digit rate on a constant-currency basis.

Kimberly-Clark's China Disruption Has a Measurable Cost

The China issue reduced consolidated second-quarter organic sales growth by approximately 50 basis points. Within International Personal Care, it created a roughly 140-basis-point organic sales headwind and about a 440-basis-point drag on operating profit.

Independent testing by a government-certified third party confirmed the quality and safety of the affected products, refuting the allegations. The commercial damage nevertheless remained meaningful, and management expects the issue to pressure sales and profits in the near term.

KMB Still Has Margin Support From Productivity

Kimberly-Clark offset part of the sales pressure with cost execution. Adjusted gross margin expanded 190 basis points year over year to 38.8%, while gross productivity reached 6.4% in the second quarter.

Adjusted operating profit increased 6.2% to $757 million and came in ahead of management’s internal expectations. Adjusted earnings from continuing operations rose 10.4% year over year to $1.80 per share, although the figure missed the Zacks Consensus Estimate of $2.00. For 2026, adjusted earnings from continuing operations are expected to grow at a high-single-digit rate on a constant-currency basis.

Kimberly-Clark Corporation Price, Consensus and EPS Surprise

Kimberly-Clark's Recovery Path Remains Uncertain

Weighted category growth in North America slowed to 1.9% from 3.7% in the prior quarter. Still, Kimberly-Clark delivered its 10th consecutive quarter of positive volume-plus-mix performance, and management expects North America to grow in line with its categories in the second half as innovation and revenue-growth-management actions scale.

Colgate-Palmolive Company CL reported 2.4% organic sales growth in second-quarter 2026, while base business earnings rose 8% to 99 cents per share. Church & Dwight Co., Inc. CHD, another consumer-products peer, generated 5.8% organic sales growth and adjusted earnings of 89 cents per share in the same quarter. Both companies provide useful context for demand and earnings trends across branded consumer staples.

KMB's Hold Signal Fits the Near-Term Uncertainty

KMB’s operating picture remains mixed. Productivity and volume-plus-mix momentum provide support, but China recovery timing, slower category growth and commodity uncertainty limit visibility. The stock trades at 14.75X forward 12-month earnings, below the industry’s 18.28X and its one-year median of 14.63X, suggesting some of the operating uncertainty is reflected in valuation.

Image Source: Zacks Investment Research

KMB currently carries a Zacks Rank #3 (Hold). It has a Value Score of C, a Growth Score of C, a Momentum Score of F and a VGM Score of C. Those middle-of-the-road Value, Growth and VGM readings, together with weak momentum, fit a neutral near-term setup rather than a strong style-based signal. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research